INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 22 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q3 2014. The put-call ratio across all filers is 28.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 100 | -80.0% | 0.00% | – |
Q4 2017 | $0 | – | 500 | +150.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 200 | -80.0% | 0.00% | – |
Q2 2017 | $3,000 | +200.0% | 1,000 | +233.3% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 300 | +50.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 200 | -71.1% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 692 | -42.7% | 0.00% | – |
Q4 2015 | $2,000 | +100.0% | 1,208 | +202.0% | 0.00% | – |
Q3 2015 | $1,000 | -90.9% | 400 | -88.8% | 0.00% | -100.0% |
Q2 2015 | $11,000 | -80.0% | 3,580 | -81.8% | 0.00% | -85.7% |
Q1 2015 | $55,000 | +37.5% | 19,637 | +10.9% | 0.01% | +75.0% |
Q4 2014 | $40,000 | 0.0% | 17,703 | +33.2% | 0.00% | 0.0% |
Q3 2014 | $40,000 | +14.3% | 13,287 | +41.4% | 0.00% | 0.0% |
Q2 2014 | $35,000 | +337.5% | 9,396 | +457.6% | 0.00% | +300.0% |
Q1 2014 | $8,000 | +166.7% | 1,685 | +108.0% | 0.00% | 0.0% |
Q4 2013 | $3,000 | – | 810 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 72,787 | $219,000 | 0.22% |
Tekla Capital Management LLC | 1,404,000 | $4,226,000 | 0.20% |
FIRST MIDWEST BANK TRUST DIVISION | 49,372 | $149,000 | 0.02% |
Tower Research Capital LLC (TRC) | 13,287 | $40,000 | 0.00% |
A.R.T. Advisors, LLC | 17,910 | $53,000 | 0.00% |
PNC FINANCIAL SERVICES GROUP, INC. | 12,000 | $36,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 25 | $0 | 0.00% |
AMERIPRISE FINANCIAL INC | 30,000 | $90,000 | 0.00% |
1832 Asset Management L.P. | 12 | $0 | 0.00% |
DEUTSCHE BANK AG\ | 192,676 | $579,000 | 0.00% |